Michigan State University main website

Richard Neubig

Helping Fight Heart Disease Before It Starts

Friday, February 5, 2021
Photo of a baby with an adult hand holding a red heart.

Spartan researchers have been awarded $2.2 million to investigate how the diets of expecting mothers could affect their babies’ heart health. Nearly one out of every 100 babies…

Read More

Outsmarting Antibiotic Resistance

Wednesday, March 4, 2020
Pharmaceutical drugs in supply chain

We live in a critical time when bacteria have demonstrated an ability to develop resistance to every known antibiotic, and new antibiotic development has been nearly nonexistent for…

Read More

New Drug Combos May Prevent Resistance to Melanoma Treatments

Friday, November 8, 2019
birds eye view of people on beach

A Michigan State University study led by a physiology graduate student in the College of Human Medicine has found that new drug combinations may prevent melanoma, an often…

Read More

MSU Faculty Named ASPET Fellows

Thursday, September 26, 2019
Test tubes and pipette in lab

Three people with ties to Michigan State University and the Department of Pharmacology and Toxicology have been named to the 2019 inaugural class of Fellows of the American Society of…

Read More

Advancing Science for Children with Epilepsy and Movement Disorders

Monday, June 3, 2019
Research holds promise for children suffering from epilepsy and movement disorders

In 2013 while Richard Neubig, professor and chair of MSU’s pharmacology and toxicology department, was conducting research on cardiovascular disease using mouse models with a Gnao1 protein mutation,…

Read More

CRISPR Research Tackles Rare Genetic Disorder in Children

Wednesday, June 13, 2018

Michigan State University scientists will use the latest CRISPR technology to study two extremely rare genetic mutations that leave children severely disabled with seizures and involuntary movements. CRISPR,…

Read More

MSU Scientists Study Gene Causing Children’s Seizures

Thursday, July 27, 2017
Richard Neubig

Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for…

Read More

Promising New Drug Stops Spread of Melanoma by 90 Precent

Wednesday, January 4, 2017
Richard Neubig and Kate Appleton

Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule…

Read More

Four MSU Scientists Named AAAS Fellows

Monday, November 23, 2015
Burton, Kirkpatrick, Neubig and Robertson - AAAS fall 2015

This year, four Michigan State University scientists were named AAAS Fellows by the American Association for the Advancement of Science. This national recognition is awarded to researchers for…

Read More

Precision Medicine for Systemic Sclerosis through Pharmacologic Profiling

Thursday, November 12, 2015

Richard Neubig, chair of the Department of Pharmacology and Toxicology at Michigan State University, discusses the potential for pharmacological intervention in scleroderma/systemic sclerosis cases. This presentation was given at…

Read More